Codiak BioSciences Inc. said it has filed for U.S. bankruptcy protection in the latest blow to the struggling drug developer’s ambitions of making a COVID-19 vaccine.
Tag Archive for: Codiak BioSciences
Six months after its official launch by Flagship Ventures, Massachusetts-based Vesalius Therapeutics is laying off 43% of its staff. With a current headcount of 67, the company is slashing 29 jobs.
inch Therapeutics is slashing its headcount by around 37% and suspending its planned Phase I study in autism one week after Takeda withdrew from its multi-year collaboration, the company announced Thursday.
